Phil S. Baran

Phil S. Baran
Name	Phil S. Baran
Birth date	1977
Birth place	Buenos Aires, Argentina
Nationality	American
Fields	Organic chemistry, Synthetic chemistry, Natural product synthesis
Workplaces	Scripps Research Institute, University of Pennsylvania, University of California, Berkeley
Alma mater	University of California, San Diego, Scripps Research
Doctoral advisor	K. C. Nicolaou
Known for	Synthetic methodology, Total synthesis, Electrochemical methods

Phil S. Baran is an American organic chemist noted for innovations in synthetic chemistry, total synthesis, and methodology development. His laboratory has advanced strategies for constructing complex natural products, developed new reagents and reactions, and influenced pharmaceutical and agrochemical research. He has held faculty appointments at leading institutions and received numerous awards for chemical synthesis and innovation.

Early life and education

Born in Buenos Aires, Baran emigrated to the United States where he pursued undergraduate studies at the University of California, San Diego and graduate studies with K. C. Nicolaou at The Scripps Research Institute. During his doctoral work he engaged with projects connected to the synthesis of complex natural product targets and collaborations involving groups at Harvard University, Massachusetts Institute of Technology, and the California Institute of Technology. Postdoctoral training included interactions with researchers at institutions such as Stanford University, University of California, Berkeley, Yale University, Columbia University, and industrial partners like Merck & Co. and Pfizer.

Academic career and positions

Baran joined the faculty of The Scripps Research Institute before accepting a position at the University of California, Berkeley and later returning to The Scripps Research Institute in La Jolla. His career has included visiting professorships and lectures at University of Pennsylvania, Massachusetts Institute of Technology, Harvard University, California Institute of Technology, Imperial College London, ETH Zurich, Max Planck Institute for Coal Research, and Rensselaer Polytechnic Institute. He has served on advisory boards for organizations such as the National Institutes of Health, the National Science Foundation, the Gordon Research Conferences, and companies including Amgen, Genentech, and Bristol-Myers Squibb.

Research contributions and synthetic methodology

Baran’s group is recognized for developing concise strategies in total synthesis and novel reactions in organic chemistry, focusing on scalability and operational simplicity. He introduced electrochemical approaches influenced by work at Bell Labs and concepts from Kolbe electrolysis and Shono oxidation, integrating knowledge from Organometallic chemistry groups at University of Chicago and University of California, Santa Barbara. His methodologies include radical-mediated couplings, oxidative coupling techniques, C–H functionalization strategies building on research from Columbia University and University of Michigan, and stereoselective union reactions inspired by studies at ETH Zurich and Max Planck Institute. Collaborations with researchers at Stanford University, University of Illinois Urbana–Champaign, University of North Carolina at Chapel Hill, and Johns Hopkins University have broadened applications toward medicinal targets investigated at Novartis, GlaxoSmithKline, and AstraZeneca.

Major discoveries and notable syntheses

Baran’s group achieved landmark total syntheses of structurally complex natural products, advancing the state of the art alongside historic syntheses by groups led by E. J. Corey, Robert Burns Woodward, Gilbert Stork, and K. C. Nicolaou. Notable targets include polycyclic alkaloids, diterpenoids, and macrocyclic polyketides that had previously been pursued by teams at Harvard University, Yale University, Columbia University, and Caltech. His team developed concise routes reducing step counts relative to approaches from Scripps Research, University of Pennsylvania, and MIT, and introduced reagent design and protecting-group-free tactics reminiscent of innovations from Nobel Prize-winning research by Richard R. Schrock and Robert H. Grubbs. Significant syntheses were compared and contrasted with those reported by groups at University of California, Los Angeles, Princeton University, University of Wisconsin–Madison, and Purdue University.

Awards and honors

Baran’s contributions have been recognized with numerous prizes and honors analogous to awards given by institutions such as the American Chemical Society, the National Academy of Sciences, the Royal Society of Chemistry, and the Gordon and Betty Moore Foundation. He has received collegiate honors comparable to the MacArthur Fellowship, the Tetrahedron Prize, the Herbert C. Brown Award, and early-career distinctions similar to the Beckman Young Investigators Award and the Presidential Early Career Award for Scientists and Engineers. He has been elected to professional societies including the American Academy of Arts and Sciences and has delivered named lectures at Massachusetts Institute of Technology, Harvard University, California Institute of Technology, Stanford University, and international symposia such as those hosted by the Royal Society and the Max Planck Society.

Selected publications and patents

Baran’s publication record includes articles in high-profile journals and venues associated with landmark work from Nature, Science, Journal of the American Chemical Society, Angewandte Chemie International Edition, and Accounts of Chemical Research. His papers have been cited alongside seminal contributions from researchers at Harvard University, MIT, Stanford University, Yale University, and ETH Zurich. Patents filed by his group and collaborators have been assigned to entities analogous to The Scripps Research Institute, pharmaceutical partners like Pfizer and Amgen, and startups incubated at University of California, San Diego and Scripps Research. Representative publication topics cover electrochemical oxidation methods, radical cross-coupling procedures, total syntheses of alkaloids and terpenes, and reagent development for streamlined synthetic routes paralleling technologies from Novartis and Roche.

Category:American chemists Category:Organic chemists